BEVERLY, MA–(Marketwired – January 05, 2016) - Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, today announces that the Company will be presenting a corporate overview at the Biotech Showcase™ 2016 investor and networking conference. The upcoming event is being held January 11-13, 2016 in San Francisco, CA at Parc 55 San Francisco, Union Square. The event is expected to bring together 2,100+ attendees representing the life science industry’s most enterprising and pioneering biotech companies and major players in the drug development arena.
Cellceutix will be presenting on Monday, January 11 at 3:00 PM local time (Pacific time) in Room Powell.
Cellceutix encourages shareholders and other investors to participate in this presentation by accessing the live webcast through the following link: http://edge.media-server.com/m/p/sfwn34cf. Note that if you are unable to listen to the live webcast, the webcast replay will be available approximately 2 hours after the presentation ends and is accessible for 3 Months
Sign-up for email alerts to be notified immediately when the presentation is available and for all notifications on developments from the Company at: http://cellceutix.com/email-alerts/#sthash.VNkn7FY9.dpbs.